Endovascular recanalization of basilar artery occlusion 80 days after symptom onset

Stroke. 2007 Apr;38(4):1387-9. doi: 10.1161/01.STR.0000260186.93667.a2. Epub 2007 Feb 22.

Abstract

Background and purpose: Acute basilar artery occlusion portends high risk of stroke and death. Thrombolysis or endovascular therapy has been limited to patients who present within hours of symptom onset. Without recanalization, acute basilar artery occlusion almost always results in death or severe disability.

Summary of case: We report a case of basilar artery occlusion and successful endovascular recanalization 80 days after symptom onset.

Conclusions: Endovascular therapy can be feasible and safe for symptomatic basilar artery occlusion at chronic stage.

Publication types

  • Case Reports

MeSH terms

  • Abciximab
  • Antibodies, Monoclonal / therapeutic use
  • Basilar Artery / drug effects*
  • Basilar Artery / physiopathology
  • Basilar Artery / surgery*
  • Cerebral Angiography
  • Chronic Disease
  • Fibrinolytic Agents / therapeutic use
  • Headache / etiology
  • Humans
  • Immunoglobulin Fab Fragments / therapeutic use
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Paresis / etiology
  • Platelet Aggregation Inhibitors / therapeutic use
  • Stents / standards*
  • Thrombolytic Therapy / methods*
  • Tissue Plasminogen Activator / therapeutic use
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Vascular Surgical Procedures / instrumentation
  • Vascular Surgical Procedures / methods*
  • Vertebrobasilar Insufficiency / pathology
  • Vertebrobasilar Insufficiency / physiopathology
  • Vertebrobasilar Insufficiency / therapy*
  • Vision, Low / etiology

Substances

  • Antibodies, Monoclonal
  • Fibrinolytic Agents
  • Immunoglobulin Fab Fragments
  • Platelet Aggregation Inhibitors
  • Tissue Plasminogen Activator
  • Abciximab